Company profile for TWi Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

TWi Pharmaceuticals, Inc. (TWi) is a technology-based special pharmaceutical company focusing on the development and commercialization of "High Barrier Generics" drugs primarily for United States. Unlike the common generic drugs, developing high barrier generic drugs require a full array of expertise, including advanced scientific research, process development, patent analysis, regulatory compliances, and market and competitio...
TWi Pharmaceuticals, Inc. (TWi) is a technology-based special pharmaceutical company focusing on the development and commercialization of "High Barrier Generics" drugs primarily for United States. Unlike the common generic drugs, developing high barrier generic drugs require a full array of expertise, including advanced scientific research, process development, patent analysis, regulatory compliances, and market and competition analysis. TWi focuses on the development of the following two categories of high barrier generic drugs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
4F, No. 41, Lane 221, Kang Chien Rd., Nei Hu Dist. Taipei 114
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/takeda-faces-another-pay-delay-antitrust-lawsuit-one-cvs-over-heartburn-drug-dexilant

FIERCE PHARMA
10 Sep 2025

https://www.expresspharma.in/strides-pharma-subsidiary-receives-usfda-approval-for-60-mg-fluoxetine-tablets/

EXPRESSPHARMA
18 Sep 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216782

FDA
01 Jun 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217054

FDA
27 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202666

FDA
16 Sep 2022

https://bora-corp.com/bora-expands-its-cdmo-capabilities-as-it-makes-landmark-acquisition-of-twi-pharmaceuticals/

PRESS RELEASE
13 Sep 2022

FDF Dossiers

read-more
read-more

01

Brand Name : TENORMIN

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : TENORMIN

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : TENORMIN

Dosage Strength : 50MG

Packaging :

Approval Date : 1982-01-01

Application Number : 18240

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : TENORMIN

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : TENORMIN

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : TENORMIN

Dosage Strength : 100MG

Packaging :

Approval Date : 1982-01-01

Application Number : 18240

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : TENORMIN

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : TENORMIN

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : TENORMIN

Dosage Strength : 25MG

Packaging :

Approval Date : 1990-04-09

Application Number : 18240

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : TENORETIC 100

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : TENORETIC 100

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : TENORETIC 100

Dosage Strength : 100MG;25MG

Packaging :

Approval Date : 1984-06-08

Application Number : 18760

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : TENORETIC 50

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : TENORETIC 50

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : TENORETIC 50

Dosage Strength : 50MG;25MG

Packaging :

Approval Date : 1984-06-08

Application Number : 18760

Regulatory Info : RX

Registration Country : USA

blank

06

Brand Name : FORFIVO XL

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : FORFIVO XL

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : FORFIVO XL

Dosage Strength : 450MG

Packaging :

Approval Date : 2011-11-10

Application Number : 22497

Regulatory Info : RX

Registration Country : USA

blank

07

Brand Name : BUPROPION HYDROCHLOR...

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : BUPROPION HYDROCHLOR...

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : BUPROPION HYDROCHLORIDE

Dosage Strength : 150MG

Packaging :

Approval Date : 2017-11-03

Application Number : 210081

Regulatory Info : DISCN

Registration Country : USA

blank

08

Brand Name : BUPROPION HYDROCHLOR...

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : BUPROPION HYDROCHLOR...

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : BUPROPION HYDROCHLORIDE

Dosage Strength : 300MG

Packaging :

Approval Date : 2017-11-03

Application Number : 210081

Regulatory Info : DISCN

Registration Country : USA

blank

09

Brand Name : FENOFIBRIC ACID

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : FENOFIBRIC ACID

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : CAPSULE, DELAYED RELEASE...

Brand Name : FENOFIBRIC ACID

Dosage Strength : EQ 45MG FENOFIBRIC ACI...

Packaging :

Approval Date : 2019-07-05

Application Number : 210469

Regulatory Info : DISCN

Registration Country : USA

blank

10

Brand Name : FENOFIBRIC ACID

BIO Partnering at JPM
Not Confirmed
arrow

Brand Name : FENOFIBRIC ACID

arrow
BIO Partnering at JPM
Not Confirmed

TWi Pharmaceuticals

Dosage Form : CAPSULE, DELAYED RELEASE...

Brand Name : FENOFIBRIC ACID

Dosage Strength : EQ 135MG FENOFIBRIC AC...

Packaging :

Approval Date : 2019-07-05

Application Number : 210469

Regulatory Info : DISCN

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty